Caibin Sheng

Caibin Sheng

Auto-generated profile, based on publicly available information

Caibin Sheng

Disease area Oncology, Novartis Institute for Biomedical Research, CH-4002 Basel, Switzerland

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2021 in Cell Stem Cell
Verified
Journal Article
Closed access
TSTianliang Sun
Tianliang Sun
SAStefano Annunziato
Stefano Annunziato
SBSebastian Bergling
Sebastian Bergling
CSCaibin Sheng
Caibin Sheng
VOVanessa Orsini
Vanessa Orsini
JTJan S. Tchorz
Jan S. Tchorz

2 July 2021 in Science Advances
Verified
Journal Article
Open access
PDF file
RLRui Lopes
Rui Lopes
KSKathleen Sprouffske
Kathleen Sprouffske
CSCaibin Sheng
Caibin Sheng
EUEsther C. H. Uijttewaal
Esther C. H. Uijttewaal
AWAdriana Emma Wesdorp
Adriana Emma Wesdorp
GGGiorgio G. Galli
Giorgio G. Galli
Combination of functional epigenomics and single-cell CRISPR screens reveals that ER exerts its oncogenic role via downstream TFs.

14 January 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
CSCaibin Sheng
Caibin Sheng
RLRui Lopes
Rui Lopes
GLGang Li
Gang Li
SSSven Schuierer
Sven Schuierer
AWAnnick Waldt
Annick Waldt
AWAntoine de Weck
Antoine de Weck
Droplet-based single-cell omics, including single-cell RNA sequencing (scRNAseq), single-cell CRISPR perturbations (e.g., CROP-seq), and single-cell protein and transcriptomic profiling (CITE-seq) hold great promise for comprehensive cell profiling and genetic screening at the single-cell resolution. However, these technologies suffer from substantial noise, among which ambient signals present in the cell suspension may be the predominant source. Current models to address this issue are highly technology-specific and relatively scRNAseq-centric. while a universal model to describe the noise across these technologies may reveal this common source, improving the denoising accuracy. To this end, we explicitly examined these unexpected signals in multiple datasets across droplet-based technologies, summarised a predictable pattern, and developed single-cell Ambient Remover (scAR) – a hypothesis-driven machine learning model to predict and remove ambient signals (including mRNA counts, protein counts, and sgRNA counts) at the molecular level. We benchmarked scAR on three technologies – single-cell CRISPR screens, CITE-seq, and scRNAseq along with the state-of-the-art single-technology-specific approaches. scAR showed high denoising accuracy for each type of dataset.

3 July 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
IBInês A. M. Barbosa
Inês A. M. Barbosa
RGRajaraman Gopalakrishnan
Rajaraman Gopalakrishnan
SMSamuele Mercan
Samuele Mercan
TMThanos P. Mourikis
Thanos P. Mourikis
TMTyphaine Martin
Typhaine Martin
GGGiorgio G. Galli
Giorgio G. Galli
YAP is a key transcriptional co-activator of TEADs, it regulates cell growth and is frequently activated in cancer. In Malignant Pleural Mesothelioma (MPM), YAP is activated by loss-of-function mutations in upstream components of the Hippo pathway, while, in Uveal Melanoma (UM), YAP is activated in a Hippo-independent manner. To date, it is unclear if and how the different oncogenic lesions activating YAP impact its oncogenic program, which is particularly relevant for designing selective anti-cancer therapies. Here we show that, despite YAP being essential in both MPM and UM, its interaction with TEAD is unexpectedly dispensable in UM, limiting the applicability of TEAD inhibitors in this cancer type. Systematic functional interrogation of YAP regulatory elements in both cancer types reveals convergent regulation of broad oncogenic drivers in both MPM and UM, but also strikingly selective programs. Our work reveals unanticipated lineage-specific features of the YAP regulatory network that provide important insights to guide the design of tailored therapeutic strategies to inhibit YAP signaling across different cancer types.